Pembrolizumab trials for Advanced Non Small Cell Lung Cancer

All Pembrolizumab trials · All Advanced Non Small Cell Lung Cancer trials

Phase breakdown

Recruiting trials studying Pembrolizumab for Advanced Non Small Cell Lung Cancer

• Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
  NCT06868732 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
  NCT04613596 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 770 locations
• SSGJ-707 in Advanced Non-Small Cell Lung Cancer
  NCT06980272 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer
  NCT05777603 · Phase: Phase 1 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  NCT07222566 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 440 locations
• Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
  NCT06908993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 29 locations

Common questions

How many trials study Pembrolizumab for Advanced Non Small Cell Lung Cancer?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.